Alk-Abello A/S ALK-ABELLO B ORD SHS
Alk-Abello A/S ALK-ABELLO B ORD S.../ DK0061802139 /
0OIR
|
24/05/2024 16:54:33
|
Chg.
-
|
Volume |
Bid06:00:04 |
Demandez à06:00:04 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
149.45DKK
|
-
|
3,365
Chiffrre d'affaires: 465,298.70 |
-Bid taille: - |
-Ask la taille: - |
31.2 Mrd.DKK |
- |
93.09 |
Description de l'entreprise
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy.
Conseil d'administration & Conseil de surveillance
| PDG |
| Carsten Hellmann |
| Conseil d'administration |
| Claus Steensen Sølje, Søren Niegel, Henriette Mersebach |
| Conseil de surveillance |
| Anders Hedegaard, Lene Skole, Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark, Alan Main, Katja Barnkob, Nanna Carlson, Lise Lund Mærkedahl, Johan Smedsrud |
Données de l'entreprise
| Nom: |
ALK-Abelló A/S |
| Adresse: |
Boge Alle 6-8,Horsholm 2970 |
| Téléphone: |
(+45) 4574 7576 |
| Fax: |
(+45) 4574 8690 |
| Courriel: |
reception@alk-abello.com
|
| Internet: |
www.alk.net |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Per Plotnikof |
| Téléphone IR: |
+45 4574 7527 |
| IR-Fax: |
- |
| E-mail IR: |
ppidk@alk.net
|
Calendrier de l'entreprise
|
CW 34 | 23/08/2024
Interim Report 2nd Quarter/6 Months
|
|
CW 46 | 14/11/2024
Interim Report 3rd Quarter/9 Months
|
